HOME >> BIOLOGY >> NEWS
Animal studies show CA4P suppresses development and induces regression of ocular neovascularization

Watertown, Mass., July 31, 2003 OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN) today announced the results of independent animal studies demonstrating the potential role of the Company's lead compound, Combretastatin A4 Prodrug (CA4P), in preventing and treating certain retinal degenerative diseases. Findings of the study are published in the current issue of the peer-reviewed journal Investigative Ophthalmology and Visual Science (IOVS).

The studies were conducted at The Johns Hopkins University School of Medicine by a team of researchers including Peter A. Campochiaro, M.D., a professor of ophthalmology at the school's renowned Wilmer Eye Institute. Dr. Campochiaro and Assistant Professor of Ophthalmology Quan Dong Nguyen, M.D. are leading the current Phase I/II clinical trial of CA4P in patients with wet age-related macular degeneration, known as wet AMD. Between 2 million and 3 million people in the United States have significant vision loss caused by wet AMD.

"The pre-clinical research produced by Dr. Campochiaro and his colleagues, as well as several other pre-clinical ophthalmic models using CA4P, provided the impetus for OXiGENE to move CA4P into human trials at Johns Hopkins," said Fred Driscoll, OXiGENE's president and CEO. "We are very pleased that Dr. Campochiaro considered the data from this study compelling enough to take CA4P into trials at one of the world's leading research institutions."

The study was designed to gauge CA4P's ability to suppress the development of choroidal neovascularization (CNV), a condition in which aberrant blood vessels beneath the retina leak blood and fluid into the retina. CNV is the primary cause of severe vision loss in patients with retinal degenerative diseases such as wet AMD. Researchers conducted experiments using transgenic mice with CNV caused by an over expression of vascular endothelial growth factor in the retina (rho/VEGF mice) and mice with laser-induced rupture of Bruch's memb
'"/>

Contact: Scott Solomon
ssolomon@investorrelations.com
617-542-5300
Sharon Merrill Associates, Inc.
31-Jul-2003


Page: 1 2

Related biology news :

1. Animal research suggests plant estrogens in soy do not increase breast cancer risk
2. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
3. Animal studies show promise treating severe chronic pain
4. UF researcher: Animals think in their own way, but unlike humans
5. Animal study demonstrates carbon monoxide may help heart patients
6. Animals can be induced to cooperate if partners reciprocate and benefits accumulate
7. Animal study finds embryonic stem cells can repair heart muscle
8. Animal welfare can now be objectively measured
9. Animals regulate their numbers by own population density
10. UF researchers score gene therapy advance: Animal study shows high blood pressure prevented in future generations
11. Experimental Staph Vaccine Broadly Protective In Animal Studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/18/2018)... POWAY, Calif. (PRWEB) , ... December 18, 2018 , ... ... Dressage. He has been competing for many years however in 2006, he had ... a trot. It was determined that he suffered from cartilage degeneration in his ...
(Date:12/13/2018)... ... December 13, 2018 , ... Study Protocol Summary of QC Procedure , 1 ... first assessment performed at the site., 3 - Three photos captured with Apple iPad ... in BOX., 5 - Photos moved to eAdjudication® and submitted to Reviewers., 6 - ...
(Date:12/13/2018)... , ... December 12, 2018 , ... ... advancement of regenerative cellular therapy, has announced the launch of Maxx-Cell, the world's ... a gold standard approach of aspirating a patients autologous bone marrow cells. Maxx™-Cell ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... ... January 11, 2019 , ... Drawing on over 22 ... January 22, 2019 at 2:30pm EST will explore some of the key lessons that ... using one vendor vs. using multiple vendors, and find out how to ensure that ...
(Date:1/8/2019)... , ... January 08, 2019 , ... The American ... grant recipients were named by a selection committee made up of industry leaders identified ... The Career Development grants are mentored awards created to support ASGCT members designing transformative ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, ... cancer, today announced the founding of a scientific and medical advisory board (SMAB). ... key leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life ... the life sciences industry, unveiled a completely redesigned website at http://www.usdm.com . ... browsing experience for their valued clients and business partners. , The website ...
Breaking Biology Technology:
Cached News: